Page last updated: 2024-11-04

sulforaphane and Dermatitis, Atopic

sulforaphane has been researched along with Dermatitis, Atopic in 3 studies

sulforaphane: from Cardaria draba L.
sulforaphane : An isothiocyanate having a 4-(methylsulfinyl)butyl group attached to the nitrogen.

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research Excerpts

ExcerptRelevanceReference
"Sulforaphane was reported to ameliorate inflammatory responses."5.72Attenuation of experimentally induced atopic dermatitis in mice by sulforaphane: effect on inflammation and apoptosis. ( Alyoussef, A, 2022)
"Sulforaphane was reported to ameliorate inflammatory responses."1.72Attenuation of experimentally induced atopic dermatitis in mice by sulforaphane: effect on inflammation and apoptosis. ( Alyoussef, A, 2022)
"Atopic dermatitis is a chronically relapsing pruritic inflammatory skin disease."1.36Sulforaphane suppresses TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-κB in human keratinocytes. ( Choi, BM; Jang, SI; Jeong, SI, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Alyoussef, A1
Wu, W1
Peng, G1
Yang, F1
Zhang, Y1
Mu, Z1
Han, X1
Jeong, SI1
Choi, BM1
Jang, SI1

Other Studies

3 other studies available for sulforaphane and Dermatitis, Atopic

ArticleYear
Attenuation of experimentally induced atopic dermatitis in mice by sulforaphane: effect on inflammation and apoptosis.
    Toxicology mechanisms and methods, 2022, Volume: 32, Issue:3

    Topics: Animals; Apoptosis; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Inflammation; Isothiocyan

2022
Sulforaphane has a therapeutic effect in an atopic dermatitis murine model and activates the Nrf2/HO‑1 axis.
    Molecular medicine reports, 2019, Volume: 20, Issue:2

    Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Dermatitis, Atopic; Disease Models, Animal; Female;

2019
Sulforaphane suppresses TARC/CCL17 and MDC/CCL22 expression through heme oxygenase-1 and NF-κB in human keratinocytes.
    Archives of pharmacal research, 2010, Volume: 33, Issue:11

    Topics: Brassica; Chemokine CCL17; Chemokine CCL22; Chemokines, CC; Chemoprevention; Dermatitis, Atopic; Gen

2010